Study finds one protein that mitigates Huntington's disease, and one that exacerbates it

Researchers found that inhibiting GSK-3 led to less defects in the axonal transport process and less neuronal cell death, while inhibiting ERK1 led to more transport problems and more cell death.

Researchers found that inhibiting GSK-3 led to less defects in the axonal transport process and less neuronal cell death, while inhibiting ERK1 led to more transport problems and more cell death.

Read more https://www.sciencedaily.com/releases/2025/05/250505171020.htm